COMPASS

Pharmaceuticals for the treatment of mental health conditions, namely, pharmaceuticals for the treatment of depression, anxiety, bipolar disorder, post-traumatic stress disorder, and eating disorders; Psychoactive and psychedelic medicinal preparations for the treatment of depression, anxiety, bipolar disorder, post-traumatic stress disorder, and eating disorders

Wearable computers in the nature of smartphones, smart glasses and activity trackers, all for monitoring and managing mental health and communicating mental health information; Wearable computers in the nature of smartphones, smart glasses and activity trackers, all for monitoring and managing depression and communicating information on depression; Downloadable computer software for monitoring and managing depression and communicating information on depression; Downloadable computer software applications for mobile devices for monitoring and managing depression and communicating information on depression

Wearable medical monitors used to measure biometric data for managing mental health and communicating mental health information for medical use; Wearable medical monitors used to measure biometric data for managing depression and communicating information on depression for medical use

Advertising and publicity services to promote public awareness of mental health conditions; Advertising and publicity services to promote public awareness of depression

Provision of educational services, namely, training services in the field of mental health conditions, treatment of mental health conditions, depression, treatment of depression, psychoactive medicines, and psychedelic medicines

Therapy for the treatment of mental health conditions using psychoactive and psychedelic medicinal preparations, namely, therapy using psychoactive and psychedelic medicinal preparations for the treatment of depression, anxiety, bipolar disorder, post-traumatic stress disorder, and eating disorders; Provision of information relating to mental health and mental healthcare, namely, provision of information relating to the use of psychoactive and psychedelic medicinal preparations for the treatment of depression, anxiety, bipolar disorder, post-traumatic stress disorder, and eating disorders